#United States #New York #Clinical Trials #ProofPilot #STUDY RAIDAR

ProofPilot Launches STUDY RAIDAR

ProofPilot, a trailblazer in streamlining clinical trials, recently announced the launch of STUDY RAIDAR, a cutting-edge AI-driven intelligence layer that aims to revolutionize how clinical studies are managed. This innovative feature enhances the existing platform's capabilities by continuously analyzing data related to study design, site behavior, and enrollment patterns. The objective is clear: to identify potential risks and provide actionable recommendations before minor issues escalate into significant challenges that could derail the trial and inflate costs.

As clinical trials grapple with escalating expenses, the need for more efficient management tools has never been more pressing. A report by the Tufts Center for the Study of Drug Development reveals that a staggering 76% of Phase I–IV trials require amendments, a sharp increase from 57% just a few years ago in 2015. Moreover, around 80% of clinical trials miss their initial enrollment timelines, translating into substantial revenue losses every day as delays mount. What’s alarming is that most of these setbacks occur despite early warning signals—indicating a need for tools to more effectively interpret these signals.

Introducing STUDY RAIDAR

STUDY RAIDAR stands at the forefront of ProofPilot’s efforts to harness AI for clinical operations. By converting historical data into proactive guidance, this tool goes far beyond traditional dashboards. Instead of requiring teams to sift through numbers and draw their conclusions, STUDY RAIDAR actively interprets ongoing and historical study data, benchmarks key performance indicators (KPIs) against similar trials, and generates prioritized recommendations tailored for specific protocols, sites, and countries.

The system is purpose-built for clinical operations, understanding terminologies around enrollment targets, risks associated with amendments, site activation complexity, and visit burdens. Its seamless integration within the ProofPilot platform means that study stakeholders have access to up-to-date intelligence that directly supports their decision-making processes, all while ensuring data security and privacy.

Protocol Intelligence: Catching Costly Design Flaws

Another groundbreaking feature is the Protocol Intelligence capability, a pre-study function housed within the Enrollment Forecaster. This tool rigorously tests the study protocol against real-world operational conditions prior to its finalization. Leveraging the capabilities of STUDY RAIDAR, it assesses the protocol against four critical factors that influence enrollment success: eligibility criteria, visit burden, site activation complexity, and operational performance, all of which are benchmarked against comparable studies. Each factor receives a dedicated score along with actionable recommendations that can be employed to refine the initial design.

Connecting protocol design with enrollment planning not only improves the accuracy of forecasts, but also provides insights into how each design choice impacts real-world execution. This connection helps prevent costly amendments, change orders, and schedule disruptions tied to unrecognized design risks.

Enrollment Optimizer: A Shift to Proactive Management

The Enrollment Optimizer Prediction tool transforms how enrollment is managed once a study is underway. By comparing actual enrollment numbers with planned targets, it utilizes historical data to forecast whether a trial will meet its enrollment goals. It doesn't stop there—by generating essential KPIs and rolling 30-day performance assessments, it ensures that any emerging risks are identified early. This proactive approach shifts clinical operations away from merely reacting to developments and instead encourages preemptive adjustments before deadlines slip.

Enhanced Interaction Through Natural Language Processing

STUDY RAIDAR also allows sponsors to engage directly with their data through conversational AI capabilities. Researchers and sponsors can pose questions regarding trial performance in natural language, set up automated reports, and create custom data visualizations that can be pinned on dashboards for instant visibility. Such advancements eliminate the need for cumbersome manual reporting procedures and render real-time insights readily available.

Document Intelligence for Site Teams

In addition to empowering sponsors, STUDY RAIDAR significantly eases the workload for site teams as well. By enabling them to query their library of study documents directly, the tool offers immediate, cited answers to pressing questions, streamlining day-to-day operations. Whether it’s clarifying a protocol detail mid-visit or resolving a procedural query on the spot, site staff can access the information they require quickly and efficiently.

Setting a New Standard in Operational Intelligence

The introduction of STUDY RAIDAR is accompanied by MCP connector integrations, allowing researchers to link this tool to existing enterprise systems seamlessly. Rather than operating in a silo, STUDY RAIDAR integrates into the operational ecosystem, providing comprehensive insights that enrich the decision-making processes across various platforms.

As Chris Venezia, CEO of ProofPilot, stated, "The industry has accepted a staggering amount of preventable waste as the cost of doing business. Our new developments mark a significant leap towards addressing these challenges head-on, ensuring that sponsors can quantify design risks before locking protocols, manage enrollment proactively, and access the intelligence they need exactly when they need it."

Availability

STUDY RAIDAR is currently available within the ProofPilot platform. Interested parties can find more information or arrange a demonstration by visiting ProofPilot's website.

About ProofPilot

ProofPilot is dedicated to modernizing the management of clinical trials, with a focus on streamlining operations and reducing burdens on patients and site staff alike. By offering a cohesive experience from startup through to trial closeout, ProofPilot facilitates faster enrollment timelines, higher compliance, and overall enhanced quality within clinical trials.